| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |